Genkyotex SA (EUR)
GKTX
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range1.97 | 2.31
52-Wk Range1.86 | 14.00
Last Close2.26
Mkt Cap (m)18.38
Dividend yield-
ISINFR0013399474
Volume140,385
Exchange VenuePAR

Company Profile

Genkyotex SA is a biopharmaceutical company in NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes.

Key Information
Price/Earning-
Price/Book1.66
Price/Sales406.45
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -1313.73
Net Margin %-1437.91
Return on Equity-60.13
Debt/Equity0.25

Legal Documents

Prospectus
en 18/03/2014
Annual Report
en 31/12/2018

Financials

Income Statement
EUR201320142015201620172018
Revenue (m)1
Operating Income (m)-6-11-11-5-14-10
Net Income (m)-6-11-11-7-26-11
Basic EPS-32.39-7.70-7.20-4.70-3.90-1.50
Avg. Diluted Shares Outstanding (m)12278
Balance Sheet
EUR201320142015201620172018
Current Assets (m)62620171712
Non Current Assets (m)1061010
Total Assets (m)73626172722
Current Liabilities (m)343327
Total Liabilities (m)------
Total Equity (m)23020132414
Cash Flows
EUR201320142015201620172018
Operating Cash Flows (m)-6-10-12-8-9-9
Capital Expenditure (m)
Figures are quoted in EUR unless stated otherwise
0.00 (0.00%)
2.26
Last Price